A patient running a single-peptide protocol for recovery will pay differently from a patient running a three-peptide stack for longevity, body composition, and sleep optimization
Despite wide dose ranges tested (6 g/kg to 20 mg/kg), multiple administration routes (intramuscular, intraperitoneal, intravenous, oral), and varied dosing frequencies across numerous animal models, no acute lethal dose has been identified
Increased expression of VEGF stimulates angiogenesis, acting on dopamine D1 receptors, and may cause, among other things, dyskinesia, a major side effect of L-DOPA, which may further reduce the quality of life of PD patients under L-DOPA medication (Veith and Henderson 2019) Increased VEGF expression has been also documented in astrocytes, endothelial cells (ECs), and monocytes of MS patients, potentially contributing to BBB permeability and the onset of MS
These include mild soreness, redness, or a warm sensation at the injection site, brief lightheadedness or flushing shortly after administration, and occasional mild nausea in the first few sessions as the body adjusts to the lipotropic compounds